|
KIAA0753 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.87439999474759E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.20090000166329E-08 |
| Normal-vs-Stage2 |
6.224600E-03 |
| Normal-vs-Stage3 |
2.437100E-03 |
| Normal-vs-Stage4 |
3.742400E-03 |
| Stage1-vs-Stage2 |
7.141000E-01 |
| Stage1-vs-Stage3 |
6.578300E-02 |
| Stage1-vs-Stage4 |
2.220200E-01 |
| Stage2-vs-Stage3 |
3.891200E-01 |
| Stage2-vs-Stage4 |
5.990600E-01 |
| Stage3-vs-Stage4 |
7.466000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6864999999866E-06 |
| Normal-vs-AfricanAmerican |
7.9059000000048E-05 |
| Normal-vs-Asian |
2.00905958536168E-12 |
| Caucasian-vs-AfricanAmerican |
3.177500E-02 |
| Caucasian-vs-Asian |
4.4753000000286E-06 |
| AfricanAmerican-vs-Asian |
4.321000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.60573999999913E-05 |
| Normal-vs-Female |
8.75869998751E-09 |
| Male-vs-Female |
6.362100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.889900E-02 |
| Normal-vs-Age(41-60Yrs) |
6.65559996004816E-09 |
| Normal-vs-Age(61-80Yrs) |
1.204360E-04 |
| Normal-vs-Age(81-100Yrs) |
1.806230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.197000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.010000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.764600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.158500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.630400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.114200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.057390E-03 |
| Normal-vs-Grade 2 |
2.61910004795141E-09 |
| Normal-vs-Grade 3 |
4.15700000000463E-05 |
| Normal-vs-Grade 4 |
1.930370E-01 |
| Grade 1-vs-Grade 2 |
6.048300E-02 |
| Grade 1-vs-Grade 3 |
3.241900E-03 |
| Grade 1-vs-Grade 4 |
2.017500E-03 |
| Grade 2-vs-Grade 3 |
2.928100E-02 |
| Grade 2-vs-Grade 4 |
2.883500E-03 |
| Grade 3-vs-Grade 4 |
9.550300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.04490005536917E-09 |
| Normal-vs-ccB subtype |
4.917400E-03 |
| ccA subtype-vs-ccB subtype |
5.564200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04339999995595E-06 |
| Normal-vs-N1 |
1.380280E-02 |
| N0-vs-N1 |
5.120000E-01 |
|
|
